Similar studies to investigate the role of neutralising IgM in mice challenged with vaccinia virus found that neutralising IgM was detected early in infection and initiated a complement-dependent cascade in the immune response to challenge that could indicate an important role in clinical outcome (62, 63). The gene discussed is CD40LG; the disease is infection.